Tenor Capital Management’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Tenor Capital Management’s Portfolio GRNAW Stock Details GRNAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-75,000	Closed	-$998	–	428
2023 Q2	$998	Hold	75,000	–	–	﹤0.01%	410
2023 Q1	$3.83K	Hold	75,000	–	–	﹤0.01%	439
2022 Q4	$6.38K	Hold	75,000	–	–	﹤0.01%	458
2022 Q3	$17K	Hold	75,000	–	–	﹤0.01%	535
2022 Q2	$17K	Hold	75,000	–	–	﹤0.01%	614
2022 Q1	$58K	Hold	75,000	–	–	﹤0.01%	576
2021 Q4	$90K	Hold	75,000	–	–	﹤0.01%	565
2021 Q3	$76K	Hold	75,000	–	–	﹤0.01%	545
2021 Q2	$81K	Hold	75,000	–	–	﹤0.01%	599
2021 Q1	$65K	Buy	+75,000	New	+$78.2K	﹤0.01%	585

Tenor Capital Management's GRNAW Position: Q3 2023 in Review

Tenor Capital Management sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2023, closing a stake of 75,000 shares — an estimated $998 sold.

Tenor Capital Management first reported a position in GRNAW in Q1 2021 and held it in 10 quarters. The position peaked at $90K in Q4 2021. 1 fund tracked by Wall St. Rank holds GRNAW as of Q3 2023.

Tenor Capital Management reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2023 after selling out during the quarter.
Tenor Capital Management sold 75,000 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2023, an estimated $998.
Tenor Capital Management first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 10 quarters.
Tenor Capital Management's GreenLight Biosciences Holdings, PBC Warrant position peaked at $90K in Q4 2021.
1 fund tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2023.

Based on Tenor Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.